These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15942243)

  • 41. Salivary levels of matrix metalloproteinase (MMP)-9 and tissue inhibitor of matrix metalloproteinase (TIMP)-1: a pilot study about the relationship with periodontal status and MMP-9(-1562C/T) gene promoter polymorphism.
    Isaza-Guzmán DM; Arias-Osorio C; Martínez-Pabón MC; Tobón-Arroyave SI
    Arch Oral Biol; 2011 Apr; 56(4):401-11. PubMed ID: 21094936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated levels of matrix metalloproteinases-9 and -1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear palsy.
    Lorenzl S; Albers DS; Chirichigno JW; Augood SJ; Beal MF
    J Neurol Sci; 2004 Mar; 218(1-2):39-45. PubMed ID: 14759631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alzheimer's disease: unraveling the tangle.
    Bonney RC
    Am Clin Lab; 1998; 17(1):4. PubMed ID: 10177661
    [No Abstract]   [Full Text] [Related]  

  • 44. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
    Hoheisel G; Sack U; Hui DS; Huse K; Chan KS; Chan KK; Hartwig K; Schuster E; Scholz GH; Schauer J
    Tuberculosis (Edinb); 2001; 81(3):203-9. PubMed ID: 11466032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated plasma angiogenesis factors in Alzheimer's disease.
    Qin W; Jia X; Wang F; Zuo X; Wu L; Zhou A; Li D; Min B; Wei C; Tang Y; Xing Y; Dong X; Wang Q; Gao Y; Li Y; Jia J
    J Alzheimers Dis; 2015; 45(1):245-52. PubMed ID: 25690662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inflammatory marker expression and its implication in Korean ischemic stroke patients.
    Park SY; Kim MH; Kang SY; Suh JT; Lee WI
    Korean J Lab Med; 2007 Jun; 27(3):197-204. PubMed ID: 18094576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alzheimer's disease: recent progress and prospects--Part I.
    Harv Ment Health Lett; 2001 Oct; 18(4):1-4. PubMed ID: 11684504
    [No Abstract]   [Full Text] [Related]  

  • 48. [Memory mechanisms and expectancy of therapy in Alzheimer's disease].
    Vetulani J
    Neurol Neurochir Pol; 2000; 34(3):429-46. PubMed ID: 10979538
    [No Abstract]   [Full Text] [Related]  

  • 49. Alzheimer's disease: the search for causes and treatments--Part II.
    Harv Ment Health Lett; 1998 Sep; 15(3):1-5. PubMed ID: 9723017
    [No Abstract]   [Full Text] [Related]  

  • 50. Time course of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients presenting with acute coronary syndrome.
    Bertsch T; Sueselbeck T; Wolpert C; Hoffmann U; Kaden JJ; Haase KK; Borggrefe M; Brueckmann M
    Clin Chem Lab Med; 2005; 43(6):660-3. PubMed ID: 16006264
    [No Abstract]   [Full Text] [Related]  

  • 51. Preanalytical aspects regarding the measurement of metalloproteinase-9 and tissue inhibitor or metalloproteinase-1 in blood.
    Alby C; Ben Abdesselam O; Foglietti MJ; Beaudeux JL
    Clin Chim Acta; 2002 Nov; 325(1-2):183-6. PubMed ID: 12367785
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of oral adsorbent AST-120 on plasma metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 concentrations in chronic renal failure.
    Ebihara I; Nakamura T; Ushiyama C; Suzuki S; Shimada N; Koide H
    Nephron; 1999; 83(2):169. PubMed ID: 10516499
    [No Abstract]   [Full Text] [Related]  

  • 53. [Interrelationship of Matrix Metalloproteinase-9 and Its Tissue Inhibitor-1 and Blood Lipid Profile of Patients With Carotid Atherosclerosis].
    Usmanova ZA; Rosykhodzhaeva GA
    Kardiologiia; 2015; 55(9):57-8. PubMed ID: 26898096
    [No Abstract]   [Full Text] [Related]  

  • 54. A randomized controlled trial of prednisone in Alzheimer's disease.
    Koch HJ; Szecsey A
    Neurology; 2000 Oct; 55(7):1067. PubMed ID: 11061280
    [No Abstract]   [Full Text] [Related]  

  • 55. From molecular cardiology to emergency medical practice: the role of inflammatory markers.
    Vazquez J; Varon J
    Am J Emerg Med; 2012 Sep; 30(7):1210-1. PubMed ID: 22030177
    [No Abstract]   [Full Text] [Related]  

  • 56. Plasma dehydroepiandrosterone sulfate in Alzheimer's disease.
    Schneider LS; Hinsey M; Lyness S
    Biol Psychiatry; 1992 Jan; 31(2):205-8. PubMed ID: 1531304
    [No Abstract]   [Full Text] [Related]  

  • 57. Improved procedure for eluting DNA from dried blood spots.
    Yang M; Hendrie HC; Hall KS; Oluwole OS; Hodes ME; Sahota A
    Clin Chem; 1996 Jul; 42(7):1115-6. PubMed ID: 8674202
    [No Abstract]   [Full Text] [Related]  

  • 58. Survival related to plasma C-reactive-protein in nonagenarians is modified by apolipoprotein E genotype.
    Lehtimäki T; Hervonen A; Rontu R; Karhunen P; Jylhä M; Hurme M
    Clin Chem; 2007 Feb; 53(2):365-7. PubMed ID: 17259254
    [No Abstract]   [Full Text] [Related]  

  • 59. Blood ammonia and Alzheimer's disease.
    Branconnier RJ; Dessain EC; McNiff ME; Cole JO
    Am J Psychiatry; 1986 Oct; 143(10):1313-4. PubMed ID: 3766798
    [No Abstract]   [Full Text] [Related]  

  • 60. Determining the combined effect on invasiveness and carcinogenesis process: matrix metalloproteinas/tissue inhibitor of metalloproteinase ratio.
    Yalcinkaya E; Celik M; Gormel S
    Chin Med J (Engl); 2014; 127(6):1196. PubMed ID: 24622463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.